Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Canada | Publication | April 6, 2020 – 3 PM ET
The fraud triangle is a well-known tool in understanding fraud. The three sides – opportunity, incentive, and rationalization – offer an explanation to a person’s decision to commit fraud. Similarly, they offer guides to preventing fraud: by addressing the three sides of the triangle, an organization can reduce its risk of fraud.
In a financial crisis, such as we are seeing during the COVID-19 pandemic, all three sides of the fraud triangle indicate an organization is at heightened risk of fraud. Individuals and companies facing serious financial pressure have incentive to commit fraud. Where there are staff reductions, employees working from home, or management focused on critical functions only, unique opportunities arise for committing fraud. Finally, the extreme stress of the pandemic offers ample rationalizations. It is the perfect storm for fraud. As such, companies need to pay more attention than ever to appropriate controls and procedures to prevent and detect instances of fraud.
An organization should consider the following as part of its fraud prevention controls:
Fraud risk management is an important business function in these uncertain times. Companies that fail to enforce strong controls will face the consequences in the months and years to come.
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
Africa faces a stark reality: contributing less than 4% of global greenhouse gas emissions, the continent is disproportionately impacted by climate change, threatening its development and stability.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023